Do you want to skip to content? Skip to content
Contact Us Convatec Argentina Argentina Belize Belize Brasil Brasil Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Costa Rica Costa Rica Curaçao Curaçao El Salvador El Salvador Ecuador Ecuador Guatemala Guatemala Guyana Guyana Honduras Honduras Jamaica Jamaica México México Nicaragua Nicaragua Panamá Panamá Perú Perú Puerto Rico Puerto Rico República Dominicana República Dominicana Suriname Suriname Venezuela Venezuela United States (English) United States (English) België België Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Deutschland Deutschland Eesti Eesti España España France France Hrvatska Hrvatska Ireland Ireland Ísland Ísland Italia Italia Latvija Latvija Lietuva Lietuva Magyarország Magyarország Malta Malta Nederland Nederland Norge Norge Polska Polska Portugal Portugal România România Schweiz (Deutsch) Schweiz (Deutsch) Suisse (Français) Suisse (Français) Slovenija Slovenija Slovensko Slovensko Srbija Srbija Suomi Suomi Sverige Sverige Türkiye Türkiye United Kingdom United Kingdom Österreich Österreich Ελλάδα Ελλάδα България България Македонија Македонија Россия Россия Україна Україна South-Africa South-Africa ישראל ישראל الأردن الأردن الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين المملكة العربية السعودية المملكة العربية السعودية ایران ایران پاکستان پاکستان عُمان عُمان قطر قطر لبنان لبنان مصر مصر العراق العراق الكويت الكويت Australia Australia Hong Kong SAR Hong Kong SAR 中国香港 中国香港 India India Indonesia Indonesia Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Việt Nam Việt Nam ไทย ไทย 대한민국 대한민국 中国 中国 中国台湾 中国台湾 日本 日本
Convatec Convatec False /oidc-signin/en-us/

Most visited pages

Reports, results and presentations
Contact Us Convatec Argentina Argentina Belize Belize Brasil Brasil Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Costa Rica Costa Rica Curaçao Curaçao El Salvador El Salvador Ecuador Ecuador Guatemala Guatemala Guyana Guyana Honduras Honduras Jamaica Jamaica México México Nicaragua Nicaragua Panamá Panamá Perú Perú Puerto Rico Puerto Rico República Dominicana República Dominicana Suriname Suriname Venezuela Venezuela United States (English) United States (English) België België Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Deutschland Deutschland Eesti Eesti España España France France Hrvatska Hrvatska Ireland Ireland Ísland Ísland Italia Italia Latvija Latvija Lietuva Lietuva Magyarország Magyarország Malta Malta Nederland Nederland Norge Norge Polska Polska Portugal Portugal România România Schweiz (Deutsch) Schweiz (Deutsch) Suisse (Français) Suisse (Français) Slovenija Slovenija Slovensko Slovensko Srbija Srbija Suomi Suomi Sverige Sverige Türkiye Türkiye United Kingdom United Kingdom Österreich Österreich Ελλάδα Ελλάδα България България Македонија Македонија Россия Россия Україна Україна South-Africa South-Africa ישראל ישראל الأردن الأردن الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين المملكة العربية السعودية المملكة العربية السعودية ایران ایران پاکستان پاکستان عُمان عُمان قطر قطر لبنان لبنان مصر مصر العراق العراق الكويت الكويت Australia Australia Hong Kong SAR Hong Kong SAR 中国香港 中国香港 India India Indonesia Indonesia Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Việt Nam Việt Nam ไทย ไทย 대한민국 대한민국 中国 中国 中国台湾 中国台湾 日本 日本

23 March 2017

  • Expansion of Sensi-Care®  portfolio in $500m market for skin care wipes, providing customers with advanced, evidence-based1 solutions to cleanse, moisturize and protect patients’ skin

READING, UNITED KINGDOM (23 March 2017) — Convatec Group Plc (“Convatec”), a leading global medical technology company, today announced the U.S. launch of Sensi-Care®  Skin Protectant Incontinence Wipes, providing customers with an advanced solution to help protect patients with skin at risk of breakdown due to incontinence.

The launch expands the company’s presence in a growing segment of the $500 million wipes market, and adds to its portfolio that helps protect the skin, which includes Aloe Vesta®  and Sensi-Care®  cleansers, moisturizers, and moisture barriers, and supporting products such as AQUACEL®  Foam Pro dressings and Flexi-Seal®  Signal Fecal Management Systems.

Sensi-Care®  Skin Protectant Incontinence Wipes are designed to help care providers cleanse patients’ delicate skin following episodes of incontinence. Formulated with an optimal combination of skin care ingredients, the new wipes help treat and prevent incontinence-associated dermatitis (IAD).2

IAD, which is estimated to affect half of people with urinary or fecal incontinence,2  is a condition where the skin becomes irritated and inflamed and, if not treated appropriately, severely swollen and blistered. The occurrence of IAD is also associated with an increased risk for the development of pressure injuries (pressure ulcers) and infection.3

Sensi-Care®  Skin Protectant Incontinence Wipes feature a dual-texture design – smooth on one side and textured on the other – for more efficient cleansing of delicate areas. The disposable wipes may also be warmed for use, to increase patient comfort.* The ingredients in the wipes allow a caregiver to cleanse, moisturize, and protect the skin in one step.

“Episodes of urinary and fecal incontinence, distressing and uncomfortable for patients, can lead to skin damage and increase the risk of pressure injury development and infection,” said Fiona Adam, Vice President and General Manager, Advanced Wound Care. “Our Sensi-Care®  portfolio including our new incontinence wipes was developed to answer the specific needs of care providers and patients, providing advanced formulations and easy-to-use products to help clinicians lessen these risks.

“Convatec is committed to providing a comprehensive range of products that can help healthcare professionals protect patients’ skin, including advanced dressings such as AQUACEL®  Foam Pro and our Flexi-Seal®  systems for managing acute fecal incontinence.”

Sensi-Care®  Evidence-based Skin Care

In addition to caring for patients’ skin, Convatec’s Sensi-Care®  skin care range was developed to provide healthcare professionals with solutions that can help them achieve consistent clinical and economic outcomes.

Sensi-Care®  skin care products work together in a simple 1-2-3 system to cleanse, moisturize and protect sensitive skin that is already compromised. The line includes Sensi-Care®  Body Wash & Shampoo, Perineal/Skin Cleanser, Body Cream, Protective Barrier, and Clear Zinc Skin Protectant. The 3-step skin care system provides a simple and proven solution designed to help maintain skin integrity, optimize resources and ensure consistency of care1  – delivering results that benefit everyone in healthcare.

Sensi-Care®  Skin Protectant Incontinence Wipes have a skin-friendly pH level, are fragrance free, and available in convenient, re-sealable packs of eight 8”x10” wipes.

For more information about Sensi-Care®  Skin Protectant Incontinence Wipes and the company’s Sensi-Care® and Aloe Vesta®  skin care lines, visit www.convatec.com or call Convatec customer service at 1-800-422-8811.

About Convatec

Convatec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. Convatec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. www.convatecgroup.com

Enquiries

Bobby Leach, VP Group Corporate Affairs, Convatec     +44 (0)7770 842 226
Punnie Donohue, VP Communications, Convatec         +1 (908) 745 9031
Rebecca Fitchett, Finsbury                                                   +44 (0)207 251 3801

# # #

*Sensi-Care®  Skin Protectant Wipes should not be used hot, and should not be flushed.

TM/® indicate trademarks of Convatec Inc.
© 2017 Convatec Inc.
AP-017540-US

 

References :
1 Lyder CH, Shannon R, Empleo-Frazier O, McGeHee D, White C. A comprehensive program to prevent pressure ulcers in long-term care: exploring costs and outcomes. Ostomy Wound Manage. 2002;48(4):52-62
2 Beeckman D, Verhaeghe S, Defloor T, Schoonhoven L, Vanderwee K. A 3-in-1 perineal care washcloth impregnated with dimethicone 3% versus water and pH neutral soap to prevent and treat incontinence- associated dermatitis: a randomized, controlled clinical trial. J Wound Ostomy Continence Nurs. 2011;38(6):627-634
3 Doughty, D., Junkin, J., Kurz, P., Selekof, J., Gray, M., Fader, M. et al (2012) Incontinence-associated dermatitis: consensus statements, evidence-based guidelines for prevention and treatment, and current challenges. Journal of Wound Ostomy, and Continence Nursing. May-June; 39(3): 303-3215. Quiz 316-317.

Download PRESS RELEASE

PDF Download

Press Release

See all

5/13/2022

Organisation Appointments

Read more

5/13/2022

FY2017 guidance and third quarter update

Read more

5/13/2022

Convatec Introduces GentleCath™ Glide and me+™ Continence Care Programme for Intermittent Catheter Users in Europe

Read more

5/13/2022

Scrip Dividend

Read more

5/13/2022

Appointment to Executive Committee

Read more

5/13/2022

Convatec appoints two Non-Executive Directors

Read more

8/3/2017

Convatec Launches Natura™ Convex Accordion Flange™, Designed to Make Ostomy Pouch Application Easier and More Comfortable

Read more

5/12/2022

Convatec Announces 2017 Interim results

Read more

5/12/2022

03 August 2017 - Board Changes

Read more

5/12/2022

Convatec Announces Acquisition of Woodbury Holdings

Read more

5/13/2022

Announcement on Board of Directors

Read more

5/12/2022

Trading Update for the three months ended 31 March 2017

Read more